Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $85 to $94.
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $85 to $94.